Novo Nordisk A/S Earnings
NYSE: NVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
38.64+0.46 (+1.20%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$0.80
Novo Nordisk A/S earnings summary
Novo Nordisk A/S is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.80.
Summary generated from market data by MetaCap's automated system. Methodology